PREZCOBIX

Serial Number 85845782
Registration 4720657
800

Registration Progress

Application Filed
Feb 11, 2013
Under Examination
Nov 19, 2013
Approved for Publication
Sep 24, 2013
Published for Opposition
Sep 24, 2013
Registered
Apr 14, 2015

Basic Information

Serial Number
85845782
Registration Number
4720657
Filing Date
February 11, 2013
Registration Date
April 14, 2015
Published for Opposition
September 24, 2013
Renewal Date
April 14, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Mar 4, 2025
Registration
Registered
Classes
005

Rights Holder

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

79
Address
BARNAHELY
RINGASKIDDY, CO. CORK
IE

Ownership History

JANSSEN R&D IRELAND

Original Applicant
03
LITTLE ISLAND CO. CORK IE

JANSSEN R&D IRELAND

Owner at Publication
03
LITTLE ISLAND CO. CORK IE

JANSSEN SCIENCES IRELAND UC

New Owner After Publication #1
99
LITTLE ISLAND, COUNTY CORK IE

JANSSEN SCIENCES IRELAND UC

Original Registrant
99
LITTLE ISLAND, COUNTY CORK IE

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY

New Owner After Registration #1
79
RINGASKIDDY, CO. CORK IE

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Renewal Deadline
3567 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2015-04-14)
Due Date
April 14, 2035
Grace Period Ends
October 14, 2035

Application History

46 events
Date Code Type Description
Mar 4, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 4, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 4, 2025 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 4, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 30, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED
Apr 14, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 11, 2021 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 11, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 11, 2021 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 9, 2020 E815 I TEAS SECTION 8 & 15 RECEIVED
Apr 14, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 6, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 14, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER
Mar 12, 2015 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 11, 2015 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 28, 2015 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Feb 26, 2015 IUAF S USE AMENDMENT FILED
Feb 26, 2015 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 26, 2015 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 21, 2015 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 13, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2014 EX2G S SOU EXTENSION 2 GRANTED
Nov 10, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 10, 2014 EXT2 S SOU EXTENSION 2 FILED
May 21, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 20, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 20, 2014 EX1G S SOU EXTENSION 1 GRANTED
Apr 28, 2014 EXT1 S SOU EXTENSION 1 FILED
Apr 28, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 14, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 19, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2013 PUBO A PUBLISHED FOR OPPOSITION
Sep 4, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 20, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 6, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2013 ALIE A ASSIGNED TO LIE
Jul 29, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2013 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2013 GNRT F NON-FINAL ACTION E-MAILED
Apr 1, 2013 CNRT R NON-FINAL ACTION WRITTEN
Mar 26, 2013 DOCK D ASSIGNED TO EXAMINER
Feb 15, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2013 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Human pharmaceutical preparations for the treatment of viral diseases and infectious-related diseases
First Use Anywhere: Feb 2, 2015
First Use in Commerce: Feb 2, 2015

Classification

International Classes
005